Showing results (1391-1400 of 1,460) with videos related to
Sort By:
Pageof 146
Journal of the National Cancer Institute|February 8, 2022
Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After ChemotherapyElizabeth K Belcher, Eva Culakova, Nikesha J Gilmore, et al.Biological Reviews of the Cambridge Philosophical Society|March 22, 2012
Ecophylogenetics: advances and perspectivesNicolas Mouquet, Vincent Devictor, Christine N Meynard, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2026
Empirical Antibiotic Activity and Outcomes in Pediatric Gram-Negative Bloodstream Infections: A Rank-based Composite Outcome AnalysisSophie C H Wen, Melissa J Hardy, Abdullah T Aslan, et al.Human Genetics|January 26, 2002
Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's diseaseR Abraham, A Myers, F Wavrant-DeVrieze, et al.Annals of Neurology|November 18, 2000
Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrationsH Houlden, M Baker, E McGowan, et al.Journal of Internal Medicine|August 25, 2004
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentB Winblad, K Palmer, M Kivipelto, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 21, 2007
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypesJ C Schymick, Y Yang, P M Andersen, et al.Human Molecular Genetics|February 5, 1999
A full genome scan for late onset Alzheimer's diseaseP Kehoe, F Wavrant-De Vrieze, R Crook, et al.Neurology|July 11, 2007
Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutationA C Bruni, P Momeni, L Bernardi, et al.Neuroscience Letters|April 15, 1999
No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's diseaseF Wavrant-DeVrièze, V Rudrasingham, J C Lambert, et al.Pageof 146